Suchergebnisse
-
17 Resulte
-
David Kaufman - Director - has a Ph.D. in Molecular Virology & Immunology from Rockefeller University and Medical Doctorate from Weill Cornell Medical College of Cornell University.Abata Therapeutics - Gesundheitswesen - USA
-
David Baltimore - Lead Independent Director - has a PhD in Biology from Rockefeller University and Bachelor of Arts in Chemistry from Swarthmore College.Altos Labs - Biotechnologie - USA
-
Jessica Hopfield - Lead Independent Director - has a PhD in Neuroscience and Biochemistry from Rockefeller University and Master of Business Administration from Harvard Business School.Insulet - medizinische Geräte - USA
-
David Baltimore - Chairman of the Board - has a PhD in Biology from Rockefeller University and Bachelor of Arts in Chemistry from Swarthmore College.Appia Bio - Biotechnologie - USA
-
Mina Pastagia - Chief Medical Officer - has a Master in Translational Medicine from Rockefeller University and Doctor of Medicine from State University of New York Downstate Medical Center College of Medicine.Armata Pharmaceuticals - Biotechnologie - USA
-
Kevin Gorman - Chief Development Officer - has a Post-Doctoral Training from Rockefeller University and Ph.D. degree in Immunology and M.B.A. in Finance from University of California, Los Angeles.Oxitec - Biotechnologie - Großbritannien
-
Jessica Hopfield - Director - has a PhD in Neuroscience and Biochemistry from Rockefeller University and Master of Business Administration from Harvard Business School.Editas Medicine - Biotechnologie - USA
-
Jessica Hopfield - Director - has a PhD in Neuroscience and Biochemistry from Rockefeller University and Master of Business Administration from Harvard Business School.Maravai LifeSciences - Biotechnologie - USA
-
Kevin Gorman - Director - has a Post-Doctoral Training from Rockefeller University and Ph.D. degree in Immunology and M.B.A. in Finance from University of California, Los Angeles.Xencor - Biotechnologie - USA
-
Brian Wong - Director - has a PhD in Immunology from Rockefeller University and Doctor of Medicine from Joan & Sanford I. Weill Medical College of Cornell University.Plexium - Biotechnologie - USA
-
Zhong Zhong - Chief Scientific Officer - hält ein PhD der Rockefeller University.Ovid Therapeutics - Biotechnologie - USA
-
Larry Altstiel - Chief Medical Officer - has a PhD in Cell Biology, Virology & Physical Chemistry from Rockefeller University and Residency in Neurology from Columbia University Vagelos College of Physicians and Surgeons.ProMIS Neurosciences - Biotechnologie - Kanada
-
Kevin Gorman - President, Chief Executive Officer and Director - has a Post-Doctoral Training from Rockefeller University and Ph.D. degree in Immunology and M.B.A. in Finance from University of California, Los Angeles.Neurocrine Biosciences - Biotechnologie - USA
-
Brian Wong - Chief Executive Officer and Director - has a PhD in Immunology from Rockefeller University and Doctor of Medicine from Joan & Sanford I. Weill Medical College of Cornell University.Rapt Therapeutics - Biotechnologie - USA
-
David Kaufman - Director - has a Ph.D. in Molecular Virology & Immunology from Rockefeller University and Medical Doctorate from Weill Cornell Medical College of Cornell University.Hookipa Pharma - Biotechnologie - Österreich
-
David Baltimore - Director - has a PhD in Biology from Rockefeller University and Bachelor of Arts in Chemistry from Swarthmore College.Regulus Therapeutics - Biotechnologie - USA